Table 2.
Work participation, expectations of future work ability, work ability self-efficacy and symptoms immediately after treatment and at the 6-month follow-up
| After treatment | At the 6-month follow-up | Significance testing | |||
|---|---|---|---|---|---|
| N | % | N | % | Sig. | |
| Work participation (n = 97) | 0.370a | ||||
| Fully working | 56 | 58 | 65 | 67 | |
| Partially working | 21 | 22 | 10 | 10 | |
| Not working | 20 | 21 | 22 | 23 | |
| Expectations about future work ability 2 years from now (n = 60) | 0.493a | ||||
| Yes, definitely | 39 | 65 | 42 | 70 | |
| Yes, to some degree | 14 | 23 | 7 | 12 | |
| No, not really | 6 | 10 | 7 | 12 | |
| No, absolutely not | 1 | 2 | 4 | 7 | |
| Mean | SD | Mean | SD | t value | Sig. | |
|---|---|---|---|---|---|---|
| Work ability (n = 105) | 6.4 | 2.7 | 7.1 | 2.5 | − 3.003 | 0.003 |
| Generalized self-efficacy (n = 105) | 2.8 | 0.4 | 2.9 | 0.5 | − 2.072 | 0.041 |
| CORE-OM total (n = 105) | 11.2 | 5.6 | 11.3 | 5.4 | − 0.265 | 0.792 |
| CORE-OM Anxiety (n = 105) | 11.9 | 8.0 | 12.6 | 7.2 | − 0.925 | 0.357 |
| CORE-OM Depression (n = 105) | 14.0 | 8.3 | 14.4 | 9.0 | − 0.451 | 0.653 |
aMarginal homogeneity test, asymptotic significance (two-sided)